Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.09M | 18.16M | 22.55M | 25.26M | 12.39M |
| Total Receivables | 6.82M | 6.49M | 3.87M | 4.33M | 658.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 1.03M | 1.16M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 221.00K | 210.20K | -- | -- | 2.19M |
| Total Current Assets | 26.13M | 24.86M | 27.45M | 30.75M | 15.24M |
|
|
|||||
| Total Current Assets | 26.13M | 24.86M | 27.45M | 30.75M | 15.24M |
| Net Property, Plant & Equipment | 35.10K | 33.30K | 35.30K | 39.60K | 40.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 30.53M | 29.05M | 29.71M | 33.28M | 32.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 24.80K | 27.70K | 26.70K |
| Total Assets | 56.70M | 53.94M | 57.21M | 64.10M | 48.06M |
|
|
|||||
| Total Accounts Payable | 4.16M | 3.96M | 1.94M | 2.18M | 4.29M |
| Total Accrued Expenses | 2.10M | 2.00M | 2.84M | 3.18M | 1.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.53M | 3.36M | 3.35M | 3.76M | 5.72M |
| Total Other Current Liabilities | 3.53M | 3.36M | 3.35M | 3.76M | 5.72M |
| Total Current Liabilities | 9.79M | 9.31M | 8.14M | 9.11M | 11.73M |
|
|
|||||
| Total Current Liabilities | 9.79M | 9.31M | 8.14M | 9.11M | 11.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.80M | 17.89M | 16.90M | 18.93M | 18.09M |
| Total Liabilities | 28.59M | 27.20M | 25.03M | 28.04M | 29.81M |
|
|
|||||
| Common Stock & APIC | 115.75M | 110.12M | 104.14M | 116.68M | 67.17M |
| Retained Earnings | -95.54M | -90.89M | -79.08M | -88.60M | -74.29M |
| Treasury Stock & Other | 9.16M | 8.71M | 7.86M | 8.81M | 25.87M |
| Total Common Equity | 29.37M | 27.94M | 32.92M | 36.89M | 18.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.37M | 27.94M | 32.92M | 36.89M | 18.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.26M | -1.20M | -741.60K | -830.80K | -513.30K |
| Total Equity | 28.11M | 26.74M | 32.18M | 36.06M | 18.25M |
|
|
|||||